Lacrimal Stents and Intubation Systems Market to Reach USD 200 Million by 2033 at a 5.8% CAGR - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - The rising incidence of nasolacrimal duct obstruction in children and adults and growing diagnosis of eye conditions are driving demand for lacrimal stents and intubation systems. According to Strategic Revenue Insights, the global lacrimal stents and intubation systems market is projected to reach USD 200 million by 2033, registering a CAGR of 5.8% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

• Market value is projected to reach USD 200 million by 2033, at a CAGR of 5.8% from 2025 to 2033.
• Products include monocanalicular and bicanalicular stents and intubation systems in silicone, polyurethane, and other materials.
• Advances in stent materials and design are improving patient outcomes.
• North America holds the largest share, while Asia-Pacific is expected to grow fastest.
• Named market participants include FCI Ophthalmics, Beaver-Visitec International, and Kaneka Corporation.

Report URL: https://www.strategicrevenueinsights.com/industry/lacrimal-stents-and-intubation-systems-market

Tear Duct Obstruction Cases Drive Lacrimal Stent Demand

Growth is significantly influenced by the increasing prevalence of ophthalmic disorders, particularly nasolacrimal duct obstruction (NLDO), a common condition in children and adults that causes excessive tearing.

Advances in stent materials and design are improving outcomes and widening opportunities, while growing awareness and diagnosis of ophthalmic conditions are increasing demand. Improving healthcare facilities support the fastest growth in Asia-Pacific.

Market Segmentation

By Product Type: Monocanalicular Stents, Bicanalicular Stents, and Intubation Systems.

By Material Type: Silicone, Polyurethane, and Other Materials.

By End User: Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers.

By Application: Congenital and Acquired Nasolacrimal Duct Obstruction, and Others. The source does not identify a largest segment.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest market share, while Asia-Pacific is expected to witness the fastest growth. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names FCI Ophthalmics, Beaver-Visitec International, Kaneka Corporation, Cook Medical, Gunther Weiss Scientific Glass, Sinopsys Surgical, Aurolab, Rumex International Co., Medtronic, Teleflex Incorporated, Boston Scientific Corporation, and Alcon Laboratories as market participants.

Market Restraints

The high cost of lacrimal stent procedures may limit adoption in some regions, and stent insertion and removal require specialized skills.

Related Reports

https://www.strategicrevenueinsights.com/industry/smart-bandage-market

https://www.strategicrevenueinsights.com/industry/permanent-pacemaker-market

https://www.strategicrevenueinsights.com/industry/automated-erythrocyte-sedimentation-rate-analyzer-market

https://www.strategicrevenueinsights.com/industry/single-use-flexible-video-ureteroscope-urf-v-market

https://www.strategicrevenueinsights.com/industry/flexible-video-ureteroscope-urf-v-market

https://www.strategicrevenueinsights.com/industry/dental-alginate-materials-market

https://www.strategicrevenueinsights.com/industry/artificial-orthopaedic-hip-replacement-market

https://www.strategicrevenueinsights.com/industry/absorbable-gelfoam-sponge-market

https://www.strategicrevenueinsights.com/industry/patient-support-and-hold-tables-market

https://www.strategicrevenueinsights.com/industry/weight-loss-use-intragastric-balloon-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 200 million by 2033.

What is the expected CAGR of the lacrimal stents and intubation systems market?

The market is projected to expand at a CAGR of 5.8% from 2025 to 2033.

Which segment is largest in the lacrimal stents and intubation systems market?

The source does not identify a largest segment.

Which region leads the lacrimal stents and intubation systems market?

North America holds the largest market share, while Asia-Pacific is expected to witness the fastest growth.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases